PR Newswire
GOTHENBURG, Sweden , May 22, 2024 /PRNewswire/ -- Vitrolife AB (publ) has completed the acquisition of eFertility (STB Zorg B.V.) as previously communicated in the press release on 2 May 2024 .
eFertility is an innovative system and software company transforming IVF clinic management with its cutting-edge solutions: eWitness (witnessing system to track and trace each step of the IVF procedure) and eBase (a specialised EMR that is compatible with hospital information systems). eFertility has a leading presence in the Netherlands and is rapidly expanding across Europe . In 2023, the company had revenues of EUR 1.5 million with a strong sales pipeline demonstrating the increased demand for witnessing systems in the IVF market. eFertility will be reported under the Technologies business area.
Gothenburg , May 22 , 2024
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor , CEO
The information was submitted for publication, through the agency of the contact persons set out above, at 22-05-2024 13:30 CET .
Contact:
Patrik Tolf , CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com .
The following files are available for download:
Vitrolife AB (publ) completes the acquisition of eFertility |
SOURCE Vitrolife AB (publ)